Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study

about

Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study

Item

http://www.wikidata.org/entity/Q58704008

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@en

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@nl

type

Item

label

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@en

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@nl

prefLabel

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@en

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@nl

P1476

Efficacy of concurrent chemora ...... ngeal carcinoma: A pilot study

@en

P2093

Liya Zhou

http://www.w3.org/2001/XMLSchema#string

Shaomin Lin

http://www.w3.org/2001/XMLSchema#string

Shuai Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaopeng Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Lobaplatin combined with docetaxel neoadjuvant chemotherapy followed by concurrent lobaplatin with intensity-modulated radiotherapy increases the survival of patients with high-risk lymph node positive nasopharyngeal carcinoma.

An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma.

Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.

A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis

Fractionated stereotactic radiotherapy for 136 patients with locally residual nasopharyngeal carcinoma

Prognostic significance of tumor volume in nasopharyngeal carcinoma.

Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.

P304

e12503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000012503

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30235761

http://www.w3.org/2001/XMLSchema#string

P932

6160225

http://www.w3.org/2001/XMLSchema#string